Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Rivaroxaban 💬1件: Rivaroxaban2件: Rivaroxaban; Xarelto1件: F10 💬 1件: Complement and coagulation cascades 💬4件: 46, 49, 91, 210 💬
2 Warfarin 💬1件: Warfarin2件: Warfarin; Warfarin Sodium2件: NQO1,
VKORC1 💬 		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬
3 Dabigatran 💬1件: Dabigatran1件: Dabigatran1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬5件: 51, 75, 85, 91, 124 💬